Research Team

Ahu Demir, Ph.D

Equity Research, Biotechnology

Ahu Demir, Ph.D. is a Senior Research Analyst focused on biotechnology with particular interest in therapeutic areas encompassing oncology, ophthalmology and rare diseases. Dr. Demir joined Ladenburg Thalmann in 2021. Prior to Ladenburg, she served as a Senior Research Analyst at Noble Capital where she covered the life sciences sector. She started her sell-side biotechnology equity research career on Wall Street at Cantor Fitzgerald.  At Cantor, and then at Roth Capital Research Division, Dr. Demir followed a range of publicly traded biotechnology companies as an Associate Biotech Analyst, with a focus on therapeutic development in oncology, inflammatory/infectious diseases, and central nervous system (CNS) disorders.  Prior to Wall Street, she worked in the Technology Transfer Office of New York University where she helped identify and evaluate promising inventions to enable potential out-licensing transactions with biopharma companies. Dr. Demir completed her postdoctoral training at Columbia University and New York University focusing on RAS signaling in cancer.  She earned her Ph.D. in Chemistry from University of Florida. Dr. Demir holds a B.Sc. in Chemistry from Hacettepe University.

Healthcare & Life Sciences

Matthew L. Kaplan

Matthew L. Kaplan

Managing Director, Head of Healthcare Equity Research

Jeffrey S. Cohen

Jeffrey S. Cohen

Managing Director, Equity Research

Wangzhi Li, PhD

Wangzhi Li, PhD

Managing Director, Equity Research-Biotech

Michael J. Higgins

Michael J. Higgins

Managing Director, Senior Biopharmaceuticals Equity Research

Ahu Demir, Ph.D

Ahu Demir, Ph.D

Equity Research, Biotechnology

Yield-Oriented Equities

Mickey M. Schleien, CFA

Mickey M. Schleien, CFA

Managing Director, Equity Research

Christopher Nolan, CFA

Christopher Nolan, CFA

Executive Vice President, Equity Research

Telecom, Media & Technology

Jon R. Hickman

Jon R. Hickman

Managing Director, Equity Research

Glenn G. Mattson, Jr.

Glenn G. Mattson, Jr.

Vice President, Equity Research